Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA shares Impella warning | Will AI replace cardiologists? | Stress & heart damage | Doctor impaled | New semaglutide data
Saturday, September 26, 2026
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

FDA warns that certain Impella heart pump controllers may need serviced

This latest alert comes after Johnson & Johnson MedTech found that certain devices may require hardware, firmware and/or software updates to address safety concerns. 

READ MORE >
The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025.
Share on Twitter Share on Facebook Share on Linkedin

FDA warns that certain Impella heart pump controllers may need serviced

Share on Twitter Share on Facebook Share on Linkedin
The FDA has identified another safety concern with Johnson & Johnson MedTech's Automated Impella Controllers. This comes after the devices were linked to five separate recalls in 2025.
This latest alert comes after Johnson & Johnson MedTech found that certain devices may require hardware, firmware and/or software updates to address safety concerns. 
READ MORE >

Professional soccer player sues doctors, including her cardiologist, after in-game cardiac arrest

Savannah DeMelo, a professional soccer player with Racing Louisville FC, alleges that clinicians failed to properly diagnose and manage her heart disease. She collapsed on the field during a match in September 2025.

READ MORE >
Savannah DeMelo, a professional soccer player with Racing Louisville FC, has filed a lawsuit against University of Louisville Health and multiple physicians after she suffered a cardiac arrest during a match and collapsed on the field in September 2025.
Share on Twitter Share on Facebook Share on Linkedin

Professional soccer player sues doctors, including her cardiologist, after in-game cardiac arrest

Share on Twitter Share on Facebook Share on Linkedin
Savannah DeMelo, a professional soccer player with Racing Louisville FC, has filed a lawsuit against University of Louisville Health and multiple physicians after she suffered a cardiac arrest during a match and collapsed on the field in September 2025.
Savannah DeMelo, a professional soccer player with Racing Louisville FC, alleges that clinicians failed to properly diagnose and manage her heart disease. She collapsed on the field during a match in September 2025.
READ MORE >

Will AI replace cardiologists?

AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.

READ MORE >
Sanjiv Narayan, MD, MBChB, MSc, FRCP, an American Heart Association volunteer, director of the electrophysiology research and atrial fibrillation program, and co-founder of the Stanford Arrhythmia Center at Stanford Medicine, sees AI at a major inflection point in cardiology, enabling cardiologists to become more efficient, gain more detailed insights into their patients' risk factors, better answers to clinical questions and help in navigating procedures. But, he said AI will not replace cardiologists.
Share on Twitter Share on Facebook Share on Linkedin

Will AI replace cardiologists?

Share on Twitter Share on Facebook Share on Linkedin
Sanjiv Narayan, MD, MBChB, MSc, FRCP, an American Heart Association volunteer, director of the electrophysiology research and atrial fibrillation program, and co-founder of the Stanford Arrhythmia Center at Stanford Medicine, sees AI at a major inflection point in cardiology, enabling cardiologists to become more efficient, gain more detailed insights into their patients' risk factors, better answers to clinical questions and help in navigating procedures. But, he said AI will not replace cardiologists.
AI-based tools are here to stay, but one expert does not see them replacing cardiologists anytime soon. Look at recent trends in radiology, he says, to get a better idea of what cardiology's future may look like.
READ MORE >

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.

READ MORE >
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves first sirolimus drug-eluting balloon for in-stent restenosis

Share on Twitter Share on Facebook Share on Linkedin
 The U.S. Food and Drug Administration (FDA) has cleared the Cordis Selution SLR (Sustained Limus Release) Drug-Eluting Balloon (DEB) for the treatment of coronary in-stent restenosis (ISR). With this market approval, Cordis is entering the coronary drug-coated balloon market. The device is also the first sirolimus DEB cleared in the U.S.
The newly approved device from Cordis provides therapy over an extended period of time without leaving a permanent implant behind.
READ MORE >

Chronic stress linked to heart damage, other risks in new imaging study

Researchers tracked data from more than 480,000 U.K. Biobank participants, using cardiac MRI scans to identify signs of inflammation. 

READ MORE >
suicide prevention depression
Share on Twitter Share on Facebook Share on Linkedin

Chronic stress linked to heart damage, other risks in new imaging study

Share on Twitter Share on Facebook Share on Linkedin
suicide prevention depression
Researchers tracked data from more than 480,000 U.K. Biobank participants, using cardiac MRI scans to identify signs of inflammation. 
READ MORE >

First heart procedure of its kind performed in US after careful planning

Specialists from the fields of interventional cardiology and cardiac surgery collaborated to perform what is believed to be the first completely catheter-based Fontan procedure in U.S. history. The young patient's recovery was much easier than it would have been otherwise. 

READ MORE >
The Nicklaus Children’s Hospital Heart Institute was the first to perform a completely catheter-based Fontan procedure. Rather than using open-heart surgery to complete the child’s Fontan circulation, the 2-year-old born with a double-outlet right ventricle underwent a catheter-based approach to avoid open-heart surgery.
Share on Twitter Share on Facebook Share on Linkedin

First heart procedure of its kind performed in US after careful planning

Share on Twitter Share on Facebook Share on Linkedin
The Nicklaus Children’s Hospital Heart Institute was the first to perform a completely catheter-based Fontan procedure. Rather than using open-heart surgery to complete the child’s Fontan circulation, the 2-year-old born with a double-outlet right ventricle underwent a catheter-based approach to avoid open-heart surgery.
Specialists from the fields of interventional cardiology and cardiac surgery collaborated to perform what is believed to be the first completely catheter-based Fontan procedure in U.S. history. The young patient's recovery was much easier than it would have been otherwise. 
READ MORE >

Cardiologist impaled by tree branch makes a full recovery

The doctor, visiting Montana from Pennsylvania for a ski trip, says he did not even realize at first what had happened.

READ MORE >
Skiing
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist impaled by tree branch makes a full recovery

Share on Twitter Share on Facebook Share on Linkedin
Skiing
The doctor, visiting Montana from Pennsylvania for a ski trip, says he did not even realize at first what had happened.
READ MORE >

Semaglutide is improving the heart health of millions—but how? Experts are stumped

“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 

READ MORE >
obesity semaglutide tirzepatide GLP-1 drugs weight loss
Share on Twitter Share on Facebook Share on Linkedin

Semaglutide is improving the heart health of millions—but how? Experts are stumped

Share on Twitter Share on Facebook Share on Linkedin
obesity semaglutide tirzepatide GLP-1 drugs weight loss
“Our analyses could not fully ascribe the effects of semaglutide on cardiovascular disease to known risk factors with any certainty,” one researcher said after exploring years of data. "These results suggest that semaglutide should be considered as a cardiovascular disease reduction drug and not just as a weight loss drug." 
READ MORE >

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 

READ MORE >
Jennifer S. Lawton, MD
Share on Twitter Share on Facebook Share on Linkedin

Veteran surgeon to be honored by American Heart Association for groundbreaking research

Share on Twitter Share on Facebook Share on Linkedin
Jennifer S. Lawton, MD
Jennifer S. Lawton, MD, is known for her research on how to protect the heart and brain during cardiac surgeries. She has also spent her career mentoring trainees and serving in a variety of leadership positions. 
READ MORE >

Photon-counting CT accurately screens TAVR patients for signs of valve dysfunction

Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Photon-counting CT accurately screens TAVR patients for signs of valve dysfunction

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Researchers found that photon-counting CT delivered post-TAVR imaging findings comparable to transthoracic echocardiography—no sedation required. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup